Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J9272 · per 10 MG

Inj, dostarlimab-gxly, 10 mg

Products billed under this code include Jemperli.

Payment limit per 10 MG, by effective quarter, 1Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9272

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Jemperli GlaxoSmithKline LLC 00173-0898-03 50 $12,527.40

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $250.548 −$0.75 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted September 17, 2026
3Q26 $251.298 +$4.215 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted September 15, 2026
2Q26 $247.083 −$0.354 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted September 15, 2026
1Q26 $247.437 +$3.725 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted September 15, 2026
4Q25 $243.712 −$0.111 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted September 8, 2026
3Q25 $243.823 +$3.688 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted March 10, 2026
2Q25 $240.135 +$0.071 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted March 10, 2026
1Q25 $240.064 +$3.662 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted December 19, 2025
4Q24 $236.402 −$0.063 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted June 11, 2025
3Q24 $236.465 +$3.911 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted June 11, 2025
2Q24 $232.554 −$0.704 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted March 11, 2025
1Q24 $233.258 +$2.439 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted December 19, 2024
4Q23 $230.819 +$3.894 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted October 10, 2024
3Q23 $226.925 +$3.002 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted June 5, 2024
2Q23 $223.923 −$0.045 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted February 23, 2024
1Q23 $223.968 +$3.217 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted December 6, 2023
4Q22 $220.751 +$0.323 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted June 22, 2023
3Q22 $220.428 +$5.242 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted June 9, 2023
2Q22 $215.186 +$0.07 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted December 14, 2022
1Q22 $215.116 – 10 MG Inj, dostarlimab-gxly, 10 mg v1, posted June 8, 2022

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files